Pfizer fails to establish standing for patent challenge

28-04-2020

Rory O'Neill

Pfizer fails to establish standing for patent challenge

photobyphm / Shutterstock.com

Pfizer has been rebuked by judges for filing thin evidence in support of what the pharma company called its ‘self-evident’ standing to bring a patent challenge.


Pfizer, Chugai Pharmaceuticals, Genentech, Roche, patent, IPR, Patent Trial and Appeal Board, DNA, Ruxience, rituximab

LSIPR